News

Merck & Co said on Tuesday it was extending its hold on Gardasil shipments to China until at least the end of 2025 due to ...
Global pharmaceutical company Merck (NYSE:MRK) met Wall Street’s revenue expectations in Q2 CY2025, but sales fell by 1.9% ...
Merck has launched a sweeping cost-cutting effort designed to save $3 billion annually by the end of 2027, the company said ...
Along with its financial results for the second quarter of 2025, Merck revealed a restructuring plan to save $3 billion by ...
Merck is undergoing a strategic restructuring, resulting in immediate job cuts in administration, sales, and research as part of a plan to save $3 billion by 2027.
Shares of global pharmaceutical company Merck (NYSE:MRK) fell 3.2% in the afternoon session after the company reported second ...
Merck & Co. Inc. (NYSE:MRK) shares fell over 6% in early trading Tuesday after the pharmaceutical giant reported a mixed ...
The restructuring includes the elimination of certain roles and a reduction in the company’s global real estate footprint.
Merck is a strong and profitable pick meeting Benjamin Graham's criteria. Read more on why investors need to stay aware of ...
Merck said it is embarking on a multi-year cost-savings plan, which includes cuts to its workforce and real-estate footprint, ...
Merck & Co on Tuesday announced job and cost cuts that it said will save $3 billion a year, after it posted lower ...